Pseudomonas aeruginosa, a gram negative, multiple drug-resistant (MDR) biofilm forming organism associated with nosocomial infections, is the causative agent of several life-threatening diseases. Emergence of multiple drug resistance against current generation antibiotics in such pathogens is a serious problem for medical practitioners. An alternative means to control the MDR pathogens is combination therapy of antibiotic with suitable biological control measures such as lytic bacteriophages. In this study, we report the isolation and characterization of P. aeruginosa specific phage vB_PaeM_P6 which is used in combination with subminimal inhibitory concentrations (MIC) of ciprofloxacin for the control of P. aeruginosa biofilm. Synergistic activity of phage 0.05 multiplicity of infection and sub-MIC ciprofloxacin (0.75 µg/ml) treatment is reported for the inhibition of biofilm forming as well as preformed biofilms of five clinical strains of P. aeruginosa.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.